Gregory Davis
Chairman bei INOTIV, INC.
Vermögen: 459 021 $ am 31.03.2024
Profil
Gregory C.
Davis's current job is Chairman at Inotiv, Inc. Dr. Davis's former jobs include Executive Director & COO-Xigris Product Team at Eli Lilly & Co. from 1992 to 2012, and Vice President-Regulatory Affairs & Quality at Calibrium LLC from 2014 to 2015.
Dr. Davis's education history includes a doctorate degree from Purdue University and an undergraduate degree from Southeast Missouri State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INOTIV, INC.
0,16% | 01.01.2024 | 41 958 ( 0,16% ) | 459 021 $ | 31.03.2024 |
Aktive Positionen von Gregory Davis
| Unternehmen | Position | Beginn |
|---|---|---|
| INOTIV, INC. | Chairman | 01.08.2017 |
Ehemalige bekannte Positionen von Gregory Davis
| Unternehmen | Position | Ende |
|---|---|---|
Calibrium LLC
 Calibrium LLC Pharmaceuticals: MajorHealth Technology Calibrium LLC develops biopharmaceuticals and diabetic drugs. The company is a biotech company that develops novel peptides that helps in the treatment of diabetes and related metabolic diseases. The company was founded by Fritz French and Richard DiMarch in 2013 and is headquartered in Carmel, IN. | General Counsel | 01.01.2015 |
| ELI LILLY AND COMPANY | Director/Board Member | 01.12.2012 |
Ausbildung von Gregory Davis
| Purdue University | Doctorate Degree |
| Southeast Missouri State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| INOTIV, INC. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Calibrium LLC
Calibrium LLC Pharmaceuticals: MajorHealth Technology Calibrium LLC develops biopharmaceuticals and diabetic drugs. The company is a biotech company that develops novel peptides that helps in the treatment of diabetes and related metabolic diseases. The company was founded by Fritz French and Richard DiMarch in 2013 and is headquartered in Carmel, IN. | Health Technology |
